245 related articles for article (PubMed ID: 36858582)
1. CRISPR-Cas9-Edited SNCA Knockout Human Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons and Their Vulnerability to Neurotoxicity.
Inoue S; Nishimura K; Gima S; Nakano M; Takata K
Biol Pharm Bull; 2023; 46(3):517-522. PubMed ID: 36858582
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
[TBL] [Abstract][Full Text] [Related]
4. Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene.
Chen Y; Dolt KS; Kriek M; Baker T; Downey P; Drummond NJ; Canham MA; Natalwala A; Rosser S; Kunath T
Eur J Neurosci; 2019 Feb; 49(4):510-524. PubMed ID: 30472757
[TBL] [Abstract][Full Text] [Related]
5. Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson's disease.
Zafar F; Nallur Srinivasaraghavan V; Yang Chen M; Alejandra Morato Torres C; Schüle B
Stem Cell Res; 2022 Apr; 60():102733. PubMed ID: 35263701
[TBL] [Abstract][Full Text] [Related]
6. Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson's disease.
Mehmood A; Ali W; Din ZU; Song S; Sohail M; Shah W; Guo J; Guo RY; Ilahi I; Shah S; Al-Shaebi F; Zeb L; Asiamah EA; Al-Dhamin Z; Bilal H; Li B
Brain Behav; 2021 Aug; 11(8):e2280. PubMed ID: 34291612
[TBL] [Abstract][Full Text] [Related]
7. Modeling native and seeded Synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications.
Iannielli A; Luoni M; Giannelli SG; Ferese R; Ordazzo G; Fossati M; Raimondi A; Opazo F; Corti O; Prehn JHM; Gambardella S; Melki R; Broccoli V
Cell Death Dis; 2022 Oct; 13(10):881. PubMed ID: 36261424
[TBL] [Abstract][Full Text] [Related]
8. Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson's disease.
Guhathakurta S; Kim J; Adams L; Basu S; Song MK; Adler E; Je G; Fiadeiro MB; Kim YS
EMBO Mol Med; 2021 Feb; 13(2):e12188. PubMed ID: 33428332
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson's Disease.
Zhu XX; Zhong YZ; Ge YW; Lu KH; Lu SS
Sci Rep; 2018 Aug; 8(1):12420. PubMed ID: 30127453
[TBL] [Abstract][Full Text] [Related]
10. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
[TBL] [Abstract][Full Text] [Related]
11. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
Taylor TN; Potgieter D; Anwar S; Senior SL; Janezic S; Threlfell S; Ryan B; Parkkinen L; Deltheil T; Cioroch M; Livieratos A; Oliver PL; Jennings KA; Davies KE; Ansorge O; Bannerman DM; Cragg SJ; Wade-Martins R
Neurobiol Dis; 2014 Feb; 62():193-207. PubMed ID: 24121116
[TBL] [Abstract][Full Text] [Related]
12. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein induces the unfolded protein response in Parkinson's disease SNCA triplication iPSC-derived neurons.
Heman-Ackah SM; Manzano R; Hoozemans JJM; Scheper W; Flynn R; Haerty W; Cowley SA; Bassett AR; Wood MJA
Hum Mol Genet; 2017 Nov; 26(22):4441-4450. PubMed ID: 28973645
[TBL] [Abstract][Full Text] [Related]
14. Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein.
Mansour HM; El-Khatib AS
Ageing Res Rev; 2023 Dec; 92():102114. PubMed ID: 37924981
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons.
Qing X; Walter J; Jarazo J; Arias-Fuenzalida J; Hillje AL; Schwamborn JC
Stem Cell Res; 2017 Oct; 24():44-50. PubMed ID: 28826027
[TBL] [Abstract][Full Text] [Related]
16. Generation of a homozygous and a heterozygous SNCA gene knockout human-induced pluripotent stem cell line by CRISPR/Cas9 mediated allele-specific tuning of SNCA expression.
Schneider Y; Turan S; Koller A; Krumbiegel M; Farrell M; Plötz S; Winkler J; Xiang W
Stem Cell Res; 2022 Dec; 65():102952. PubMed ID: 36283273
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS
Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663
[TBL] [Abstract][Full Text] [Related]
18. Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P.
Barbuti P; Antony P; Santos B; Massart F; Cruciani G; Dording C; Arias J; Schwamborn J; Krüger R
Cells; 2020 Sep; 9(9):. PubMed ID: 32927687
[TBL] [Abstract][Full Text] [Related]
19. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
[TBL] [Abstract][Full Text] [Related]
20. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
